The Liver Meeting 2019-Reversing Liver Fibrosis: Predicting and Monitoring Structural Changes*

Reversing Liver Fibrosis: Predicting and Monitoring Structural Changes*

Video Transcription

Video Summary

In the video, the speaker discusses liver fibrosis as a critical issue and emphasizes the potential reversibility of fibrosis. They outline a case study of a 52-year-old woman with type 2 diabetes and high BMI presenting with liver fibrosis. The speaker talks about the importance of understanding the pathogenesis of fibrosis and mentions various treatment options, including bariatric surgery and antifibrotic therapies. They highlight the effectiveness of weight loss and exercise in improving liver health and discuss potential medications like statins, TZDs, and GLP-1 agonists. The speaker also mentions ongoing clinical trials and the potential for future antifibrotic treatments. They conclude by emphasizing the importance of assessing fibrosis, treating underlying conditions, and the ongoing research in the field.

Asset Caption

Presenter: Don Rockey

Keywords

liver fibrosis

reversibility

case study

type 2 diabetes

bariatric surgery

antifibrotic therapies